HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Myeloma News

The HealthTree News for Myeloma is a place to learn all about Myeloma in easy-to-understand language. The site features news articles, patient stories, Myeloma basics articles, and clinical trial updates with new content every week.

Navigating Multiple Myeloma: 5 Tips Learned over 5 Years

Mar. 30, 2023

Navigating Multiple Myeloma: 5 Tips Learned over 5 Years

The Hope of the Future in Black Myeloma Health Event Review

Mar. 29, 2023

The Hope of the Future in Black Myeloma Health Event Review

Peripheral-Blood Single Cell Sequencing Holds the Key to Better Treatment Outcomes

Mar. 29, 2023

Peripheral-Blood Single Cell Sequencing Holds the Key to Better Treatment Outcomes

A New Potential Stage of Precursor Condition in Multiple Myeloma

Mar. 29, 2023

A New Potential Stage of Precursor Condition in Multiple Myeloma

Clinical Trial: Daratumumab for Newly Diagnosed Older Myeloma Patients

Mar. 29, 2023

Clinical Trial: Daratumumab for Newly Diagnosed Older Myeloma Patients

Mexican Sweet Potato Skins

Mar. 28, 2023

Mexican Sweet Potato Skins

Risk of Infections Using Bispecific Antibodies in Multiple Myeloma

Mar. 23, 2023

Risk of Infections Using Bispecific Antibodies in Multiple Myeloma

Raleigh-Durham Myeloma Round Table in May 20

Mar. 22, 2023

Raleigh-Durham Myeloma Round Table in May 20

Start Slow and Stay Moving with Keith Guernsey

Mar. 22, 2023

Start Slow and Stay Moving with Keith Guernsey

The Role of a Financial Advisor and How to Choose One

Mar. 22, 2023

The Role of a Financial Advisor and How to Choose One

Clinical Trial: Bispecific Antibody Elrantanamab For Relapsed Multiple Myeloma

Mar. 21, 2023

Clinical Trial: Bispecific Antibody Elrantanamab For Relapsed Multiple Myeloma

Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal

Mar. 21, 2023

Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal

Recent Articles

Should We Be Intercepting Blood Cancers? image
Should We Be Intercepting Blood Cancers?

March 20, 2023

Clinical Trial: Screening to Improve Survival in AL Amyloidosis image
Clinical Trial: Screening to Improve Survival in AL Amyloidosis

March 16, 2023

What Multiple Myeloma Patients Think About MRD Testing image
What Multiple Myeloma Patients Think About MRD Testing

March 16, 2023

New in Myeloma

Peripheral-Blood Single Cell Sequencing Holds the Key to Better Treatment Outcomes image
Peripheral-Blood Single Cell Sequencing Holds the Key to Better Treatment Outcomes
A New Potential Stage of Precursor Condition in Multiple Myeloma image
A New Potential Stage of Precursor Condition in Multiple Myeloma
All About TECVAYLI (Teclistamab) image
All About TECVAYLI (Teclistamab)
Potential New Target for Multiple Myeloma Treatment Discovered image
Potential New Target for Multiple Myeloma Treatment Discovered
Biopsy Location Matters When it Comes to Evaluating Myeloma Genetics image
Biopsy Location Matters When it Comes to Evaluating Myeloma Genetics
Bispecific Antibody Elranatamab Moves Closer Towards a Myeloma Approval image
Bispecific Antibody Elranatamab Moves Closer Towards a Myeloma Approval
Load More

Life With Myeloma

Navigating Multiple Myeloma: 5 Tips Learned over 5 Years image
Navigating Multiple Myeloma: 5 Tips Learned over 5 Years
The Hope of the Future in Black Myeloma Health Event Review image
The Hope of the Future in Black Myeloma Health Event Review
Risk of Infections Using Bispecific Antibodies in Multiple Myeloma image
Risk of Infections Using Bispecific Antibodies in Multiple Myeloma
The Role of a Financial Advisor and How to Choose One image
The Role of a Financial Advisor and How to Choose One
Should We Be Intercepting Blood Cancers? image
Should We Be Intercepting Blood Cancers?
What Can Technology Do For Me? And How Do I Navigate It? image
What Can Technology Do For Me? And How Do I Navigate It?
Load More

Myeloma Basics

Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal image
Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal
All About IVIG (Intravenous Immunoglobulin) image
All About IVIG (Intravenous Immunoglobulin)
NK Cell Persistence & Side Effects image
NK Cell Persistence & Side Effects
NK (Natural Killer) Cell Administration image
NK (Natural Killer) Cell Administration
What are Natural Killer Cells? image
What are Natural Killer Cells?
What is Plasma Cell Enrichment and How Does it Help Obtain Better Test Results in Multiple Myeloma? image
What is Plasma Cell Enrichment and How Does it Help Obtain Better Test Results in Multiple Myeloma?
Load More

Trending Articles

Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal Types of Myeloma: High-Risk, Bi-Clonal, CNS, & Macro Focal
Risk of Infections Using Bispecific Antibodies in Multiple Myeloma Risk of Infections Using Bispecific Antibodies in Multiple Myeloma
Should We Be Intercepting Blood Cancers? Should We Be Intercepting Blood Cancers?
Start Slow and Stay Moving with Keith Guernsey Start Slow and Stay Moving with Keith Guernsey
The Role of a Financial Advisor and How to Choose One The Role of a Financial Advisor and How to Choose One

Upcoming Events

Free Resources for Blood Cancer Patients

Free Resources for Blood Cancer Patients

Apr 04 / 13:00 EDT
Building Bone Health Knowledge with Dr. Susan Bukata, UCSD

Building Bone Health Knowledge with Dr. Susan Bukata, UCSD

Apr 04 / 18:00 PDT
Miami Myeloma MRD Meeting 2023

Miami Myeloma MRD Meeting 2023

Apr 06 / 9:00 EDT
Patient Stories
articles for Patient Stories
HealthTree Research
articles for HealthTree Research
Clinical Trials
articles for Clinical Trials
HealthTree Press
articles for HealthTree Press
HealthTree
articles for HealthTree
Healthy Recipes
articles for Healthy Recipes

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech

Follow Us

facebook instagram twitter youtube

 https://www.guidestar.org/profile/45-5354811

HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2022 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811